Literature DB >> 29794653

Viral Suppression in a Nationwide Sample of HIV-Infected Children on Antiretroviral Therapy in Rwanda.

Sabin Nsanzimana1, Flannery McArdle1, Eric Remera1, Augustin Mulindabigwi1, Muhayimpundu Ribakare1, Patrick Ndimubanzi2, Eugenie Kayirangwa2, Cyprien Baribwira3, David J Riedel3, Joseph Ntaganira4.   

Abstract

Rwanda has made significant progress in expanding pediatric antiretroviral treatment coverage. This was a nationwide, cross-sectional study of pediatric HIV suppression rates. Of 292 children on antiretroviral treatment ≥12 months, 68.8% achieved viral suppression < 40 copies/ml, respectively. Rwanda achieved good pediatric viral suppression rates, comparable to those from other resource-limited settings, yet more efforts are needed to achieve the UNAIDS 90-90-90 target.

Entities:  

Mesh:

Substances:

Year:  2019        PMID: 29794653     DOI: 10.1097/INF.0000000000002101

Source DB:  PubMed          Journal:  Pediatr Infect Dis J        ISSN: 0891-3668            Impact factor:   2.129


  3 in total

1.  Prevalence and Correlates of Viral Load Suppression and Human Immunodeficiency Virus (HIV) Drug Resistance Among Children and Adolescents in South Rift Valley and Kisumu, Kenya.

Authors:  Isaac Tsikhutsu; Margaret Bii; Nicole Dear; Kavitha Ganesan; Alex Kasembeli; Valentine Sing'oei; Kevin Rombosia; Christopher Ochieng; Priyanka Desai; Vanessa Wolfman; Peter Coakley; Elizabeth H Lee; Patrick W Hickey; Jeffrey Livezey; Patricia Agaba
Journal:  Clin Infect Dis       Date:  2022-09-29       Impact factor: 20.999

2.  Attendance to HIV Antiretroviral Collection Clinic Appointments During COVID-19 Lockdown. A Single Center Study in Kigali, Rwanda.

Authors:  Gashema Pierre; Annette Uwineza; Tafadzwa Dzinamarira
Journal:  AIDS Behav       Date:  2020-12

3.  Knowledge, Attitude, and Practice Towards COVID-19 Among People Living with HIV/AIDS in Kigali, Rwanda.

Authors:  Patrick Gad Iradukunda; Gashema Pierre; Valens Muhozi; Knowledge Denhere; Tafadzwa Dzinamarira
Journal:  J Community Health       Date:  2020-10-26
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.